KKR, a global investment firm, announced the signing of definitive agreements under which funds managed by KKR will acquire Healthium Medtech Ltd., an Indian medical devices company, from an affiliate of Funds advised by Apax Partners LLP, a global private equity advisory firm. 

A special purpose vehicle owned by KKR-managed funds will acquire a controlling stake in Healthium Group, which includes Healthium, through an acquisition. Established in India in 1992, Healthium is a medical devices company specializing in the development, manufacturing, and global distribution of a wide array of surgical products. Its extensive portfolio of high-quality offerings caters to various surgical needs, encompassing wound closure, arthroscopy, and advanced wound care products. Acquired by the Apax Funds in 2018, Healthium underwent a strategic transformation from a domestic suture provider to a prominent global player in the medical devices industry. During this transition, Healthium bolstered its existing range of wound closure devices and consumables, while also venturing into new segments like arthroscopy and advanced wound care through a combination of in-house research and development initiatives and strategic mergers and acquisitions. As a result, Healthium significantly expanded its global footprint, growing from operating in 50 countries to over 90 countries today.

KKR makes its investment from its Asian Fund IV. Apax Partners and Healthium were advised by Jefferies LLC as financial advisor and Kirkland & Ellis LLP as legal counsel. KKR was advised by Moelis & Company as financial advisor and Simpson Thacher & Bartlett and AZB & Partners as legal counsel.